EUVIMEDEUVIMED entdecken
Crossref

Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis

Xiarepati Tieliwaerdi, Aakash Sheth, Marziyeh Bagheri, Yijin Wert, Alex Garton

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.7825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Xiarepati Tieliwaerdi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Apixaban dosing in atrial fibrillation/atrial flutter (AF/AFL) may not consistently follow dose-reduction criteria in routine care.

Objective

To perform a quality improvement (QI) analysis of apixaban prescribing in AF/AFL and identify factors associated with inappropriate dose reduction or failure to reduce dose when indicated.

Methods

We analyzed 179,705 deidentified anticoagulation records from January 1, 2022, to October 15, 2024. Patients were included if diagnoses contained AF/AFL and at least 1 record contained apixaban. To preserve longitudinal follow-up while limiting duplicate same-day ordering and reconciliation artifacts, we retained 1 apixaban record per patient per day and kept the latest order that day. Records for thrombus treatment were excluded. For each patient-day record, the nearest prior creatinine within 365 days was matched. Dose reduction was indicated when at least 2 criteria were present: age >=80 years, weight =1.5 mg/dL. Mixed-effects logistic regression with patient random intercept was the primary analysis.

Results

Among 1000 included patients, 98,970 patient-day apixaban records met analytic criteria. Of these, 80,286 (81.1%) were appropriately dosed, 13,830 (14.0%) were inappropriately reduced to 2.5 mg, and 3,792 (3.8%) met reduction criteria but remained on 5 mg; 43 records were unassessable and excluded from comparative modeling. In mixed-effects models, inappropriate reduction to 2.5 mg was associated with surgical specialty versus cardiology (OR 6.55, 95% CI 6.17-6.94, p

Zitieren

APA

Tieliwaerdi, X., Sheth, A., Bagheri, M., Wert, Y., & Garton, A. (2026). Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7825

Vancouver

Tieliwaerdi X, Sheth A, Bagheri M, Wert Y, Garton A. Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7825

BibTeX
@article{Tieliwaerdi2026,
  author = {Tieliwaerdi, Xiarepati and Sheth, Aakash and Bagheri, Marziyeh and Wert, Yijin and Garton, Alex},
  title = {Abstract 7825: Patterns of Inappropriate Apixaban Dosing in Atrial Fibrillation and Atrial Flutter: A Quality Improvement Analysis},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.7825}
}
Kostenlos starten →